TTP Today: Diagnosis, Management & Evolving Therapies
From HemeTalks: Conversations in Hematology Education by American Society of Hematology
May 7, 2026 · 20 min · Season 5 · Episode 22
About this episode
This episode discusses the diagnosis, management, and evolving therapies for TTP, featuring insights from Dr. Yazan Abou-Ismail and Dr. Kolton Smith.
TTP is a hematologic emergency that demands immediate recognition and treatment to prevent fatal outcomes. In this HemeTalks episode, Dr. Yazan Abou-Ismail and Dr. Kolton Smith discuss the diagnostic hallmarks, therapeutic advances, and follow-up strategies for patients with TTP. Through the lens of a clinical case, they explore the impact of caplacizumab, the importance of ADAMTS13 testing, and how to differentiate TTP from other TMAs. Tune in for practical insights that every hematologist and frontline provider should know. Learning Objectives: Recognize clinical and laboratory features indicative of TTP. Understand the evolving treatment landscape, including the role of caplacizumab. Apply principles for acute and chronic management of both congenital and acquired TTP. Clinical Pearls: Always consider iTTP diagnosis in any patient with findings of thrombotic microangiopathy, as early recognition is critical. When iTTP is suspected, it is essential to start empiric therapy immediately—untreated disease carries a high mortality risk. Monitor closely for disease exacerbation or relapse even after initial clinical response is achieved.
People in this episode
Guests: Dr. Yazan Abou-Ismail, Dr. Kolton Smith
Topics covered
- TTP
- hematologic emergency
- diagnosis
- management
- therapeutic advances
- clinical case
- thrombotic microangiopathy
Keywords
- TTP
- diagnosis
- management
- caplacizumab
- ADAMTS13
- thrombotic microangiopathy
- hematology
- clinical case
- treatment
Mentioned in this episode
Organizations: American Society of Hematology, ADAMTS13
Products: caplacizumab
More episodes of HemeTalks: Conversations in Hematology Education
- Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status · June 4, 2026 · 21 min
- Multiple Myeloma Care: Timing, Teamwork, Treatment · May 21, 2026 · 23 min
- Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento · May 21, 2026 · 22 min
- Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring · April 16, 2026 · 25 min
- New Horizons in Smoldering Multiple Myeloma · March 19, 2026 · 26 min
- Interpreting Abnormal SPEP – Is It Just MGUS? · February 19, 2026 · 27 min
Explore listener stats, chart rankings, contacts and more on the HemeTalks: Conversations in Hematology Education podcast page.